We are very grateful to the NIH for supporting the lab with the 2022 NIH Director’s New Innovator Award. The DP2 New Innovator Award will support the Ha Lab for the next 5 years to explore high-risk, high-reward research into how multiomic (genomic, transcriptomic, and epigenetic) information can be exploited from liquid biopsies to improve clinical applications and precision oncology.